Korsana Biosciences, Inc.
For the period ended Sep 8, 2026. Filed Sep 11, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Sep 8, 2026 · Filed Sep 11, 2026
Use the contents to explore the available documents and sections.
KRSA$31.05+2.0%Stored close · as of Nov 6, 2026
Contents
EX-99.4 · Pro forma notes:
Pro forma notes:
5(A) Derived from the unaudited balance sheet of Cyclerion as of June 30, 2026.
5(B) Derived from the unaudited balance sheet of Korsana as of June 30, 2026.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.